Therapeutic products from yeast

Abstract

Over the past three decades recombinant DNA methodologies for yeast have opened a plethora of new biotechnology opportunities for biotechnology?s oldest organism. It is now possible to introduce foreign genes that are capable of encoding rare proteins or new pathways that could lead to the production of rare or novel biological or chemical entities (NBEs or NCEs).